FSTL3 expression is correlated with lymph node metastasis, tumor stage, tumor size, and intravascular emboli and is associated with a poorer prognosis (Li et al., 2021a; Yang et al., 2021). This evidence concerns the gene FSTL3 and metastatic malignant neoplasm in the lymph nodes.